Trials / Completed
CompletedNCT02172339
The Pharmacokinetic, Safety and Tolerability of Tiotropium in Outpatients With Renal Impairment in Comparison to Healthy Subjects
The Pharmacokinetic, Safety and Tolerability of Tiotropium (4.8 mcg, Single i.v. Dose) in Outpatients With Renal Impairment in Comparison to Healthy Subjects (Open Label, Group Comparison, Two-center Study)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 40 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Study to investigate pharmacokinetics of a single i.v. dose of tiotropium (4.8 mcg) in patients with renal impairment in comparison to healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tiotropium, solution ampoules |
Timeline
- Start date
- 1998-04-01
- Primary completion
- 1998-12-01
- First posted
- 2014-06-24
- Last updated
- 2014-06-24
Source: ClinicalTrials.gov record NCT02172339. Inclusion in this directory is not an endorsement.